Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Journal of Substance Use
|
March 20, 2018
The Harnessing Online Peer Education (HOPE) Intervention for Reducing Prescription Drug Abuse: A Qualitative Study
Sean D Young, Keith Heinzerling
Addiction (Abingdon, England)
|
January 21, 2017
Dropout in clinical trials of pharmacological treatment for methamphetamine dependence: the role of initial abstinence
Ryan Cook, Brendan Quinn, Keith Heinzerling, et al.
The Cochrane Database of Systematic Reviews
|
April 17, 2009
Treatment for amphetamine withdrawal
Steven J Shoptaw, Uyen Kao, Keith Heinzerling, et al.
International Review of Neurobiology
|
September 2, 2014
Opportunities for the development of neuroimmune therapies in addiction
Lara A Ray, Daniel J O Roche, Keith Heinzerling, et al.
Heliyon
|
March 18, 2020
Social media as an emerging tool for reducing prescription opioid misuse risk factors
Sean D Young, Sung-Jae Lee, Hendry Perez, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
January 17, 2017
Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial
Lara A Ray, Spencer Bujarski, Steve Shoptaw, et al.
Neurosurgery
|
December 13, 2022
Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology
Daniel F Kelly, Keith Heinzerling, Akanksha Sharma, et al.
Journal of Addictive Diseases
|
January 8, 2019
Feasibility of a social media/online community support group intervention among chronic pain patients on opioid therapy
Sean D Young, Maryann Koussa, Sung-Jae Lee, et al.
Frontiers in Psychiatry
|
May 10, 2018
Pain Therapy Guided by Purpose and Perspective in Light of the Opioid Epidemic
Amie L Severino, Arash Shadfar, Joshua K Hakimian, et al.
Addiction (Abingdon, England)
|
November 16, 2011
Double-blind placebo-controlled evaluation of the PROMETA™ protocol for methamphetamine dependence
Walter Ling, Steven Shoptaw, Maureen Hillhouse, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Journal of Substance Use
|
March 20, 2018
The Harnessing Online Peer Education (HOPE) Intervention for Reducing Prescription Drug Abuse: A Qualitative Study
Sean D Young, Keith Heinzerling
Addiction (Abingdon, England)
|
January 21, 2017
Dropout in clinical trials of pharmacological treatment for methamphetamine dependence: the role of initial abstinence
Ryan Cook, Brendan Quinn, Keith Heinzerling, et al.
The Cochrane Database of Systematic Reviews
|
April 17, 2009
Treatment for amphetamine withdrawal
Steven J Shoptaw, Uyen Kao, Keith Heinzerling, et al.
International Review of Neurobiology
|
September 2, 2014
Opportunities for the development of neuroimmune therapies in addiction
Lara A Ray, Daniel J O Roche, Keith Heinzerling, et al.
Heliyon
|
March 18, 2020
Social media as an emerging tool for reducing prescription opioid misuse risk factors
Sean D Young, Sung-Jae Lee, Hendry Perez, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
January 17, 2017
Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial
Lara A Ray, Spencer Bujarski, Steve Shoptaw, et al.
Neurosurgery
|
December 13, 2022
Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology
Daniel F Kelly, Keith Heinzerling, Akanksha Sharma, et al.
Journal of Addictive Diseases
|
January 8, 2019
Feasibility of a social media/online community support group intervention among chronic pain patients on opioid therapy
Sean D Young, Maryann Koussa, Sung-Jae Lee, et al.
Frontiers in Psychiatry
|
May 10, 2018
Pain Therapy Guided by Purpose and Perspective in Light of the Opioid Epidemic
Amie L Severino, Arash Shadfar, Joshua K Hakimian, et al.
Addiction (Abingdon, England)
|
November 16, 2011
Double-blind placebo-controlled evaluation of the PROMETA™ protocol for methamphetamine dependence
Walter Ling, Steven Shoptaw, Maureen Hillhouse, et al.
Page
of 2